Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Ark Biopharmaceutical Co., Ltd.

Clinical trials sponsored by Shanghai Ark Biopharmaceutical Co., Ltd., explained in plain language.

Trials to join now! 1 Not yet recruiting 1 Completed 3 Terminated 1

New oral pill aims to fight RSV in adults

Disease control Terminated

This study tests an oral drug called AK0529 (Ziresovir) in adults aged 18 to 75 with respiratory syncytial virus (RSV) infection. Participants receive either the drug or a placebo, and researchers measure how well symptoms improve and track any side effects. The goal is to see if…

Phase: PHASE2 • Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 14:01 UTC